Alzheimer's Disease: Competitive Landscape to 2026
This report provides an in-depth insight of Global Alzheimer’s Disease Industry covering all important parameters including development trends, challenges, opportunities, key manufacturers and competitive analysis.
(EMAILWIRE.COM, August 14, 2018 ) Alzheimer’s disease (AD) is a progressive neurodegenerative disease that is characterized by memory loss, cognitive impairment, and functional decline. The degeneration of neurons starts in the brainstem before progressing to the hippocampus, frontal lobe, amygdala, parietal lobe, and temporal lobe. The cause of AD is unknown, but it appears to be multifactorial, with most research aimed at the A? peptides and tau proteins. The irregular clearance and metabolism of these proteins are likely contributors to the presentation of the disease. The risk of developing AD is believed to be determined by a combination of genetic, metabolic, behavioral, and environmental factors.
This report provides an assessment of the pipeline, clinical, and commercial landscape of AD. Overall, GlobalData expects new drug approvals to drive AD market growth over the next decade (2016-2026).
Get Sample Copy of this Report@ http://www.orbisresearch.com/contacts/request-sample/2284680
Key Players:
Biogen
Eisai Co.
F. Hoffmann-La Roche
Otsuka Pharmaceuticals
Eli Lilly
Ionis Pharmaceuticals
TauRx Therapeutics
Axsome Therapeutics
Accera
Novartis
AZTherapies
AB Science
Grifols
Shanghai Green Valley Pharmaceutical
Archer Pharmaceuticals
Changchun Huayang High-Tech
Intra-Cellular Therapies
Avanir Pharmaceuticals
Promis Neurosciences
Pfizer
Johnson & Johnson
AstraZeneca
Janssen
Allergan
Adamas Pharmaceuticals
Lundbeck
Merz Pharma GmbH
Icure Pharmaceutical
Shire
Chase Pharmaceuticals
Scope:
This report combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace. Components of the slide deck include -
- Pipeline Assessment: regional breakdown, promising late-stage products, early-stage pipeline by molecule type
- Clinical Trials Assessment: trial breakdown by phase, leading industry and non-industry sponsors, enrollment analytics
- Commercial Assessment: leading marketed products, current and future players
- Competitive Landscape Analysis: key market events (2016-2026).
Make an Inquiry before Buying@ http://www.orbisresearch.com/contacts/enquiry-before-buying/2284680
Reasons to buy:
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global AD market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global AD market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Key Points from TOC:
1. Preface 2
2. Executive Summary 6
3. Introduction 9
4. Pipeline Assessment 15
4.1 Pipeline Overview 16
4.2 Pipeline Breakdown by Region/Country 18
4.3 Pipeline Breakdown by Molecule Type and Target 19
4.4 Drug Review Designations 20
4.5 Products in Clinical Development 21
5. Clinical Trial Assessment 23
6 Commercial Assessment 32
7. Competitive Landscape Analysis (2016-2026) 35
7.1 Events Classification Overview 36
7.2 US 37
7.3 5EU 38
7.4 Japan 39
7.5 China 40
8 Appendix 42
Get More Information about the Report@ http://www.orbisresearch.com/reports/index/alzheimers-disease-competitive-landscape-to-2026
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
This report provides an assessment of the pipeline, clinical, and commercial landscape of AD. Overall, GlobalData expects new drug approvals to drive AD market growth over the next decade (2016-2026).
Get Sample Copy of this Report@ http://www.orbisresearch.com/contacts/request-sample/2284680
Key Players:
Biogen
Eisai Co.
F. Hoffmann-La Roche
Otsuka Pharmaceuticals
Eli Lilly
Ionis Pharmaceuticals
TauRx Therapeutics
Axsome Therapeutics
Accera
Novartis
AZTherapies
AB Science
Grifols
Shanghai Green Valley Pharmaceutical
Archer Pharmaceuticals
Changchun Huayang High-Tech
Intra-Cellular Therapies
Avanir Pharmaceuticals
Promis Neurosciences
Pfizer
Johnson & Johnson
AstraZeneca
Janssen
Allergan
Adamas Pharmaceuticals
Lundbeck
Merz Pharma GmbH
Icure Pharmaceutical
Shire
Chase Pharmaceuticals
Scope:
This report combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace. Components of the slide deck include -
- Pipeline Assessment: regional breakdown, promising late-stage products, early-stage pipeline by molecule type
- Clinical Trials Assessment: trial breakdown by phase, leading industry and non-industry sponsors, enrollment analytics
- Commercial Assessment: leading marketed products, current and future players
- Competitive Landscape Analysis: key market events (2016-2026).
Make an Inquiry before Buying@ http://www.orbisresearch.com/contacts/enquiry-before-buying/2284680
Reasons to buy:
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global AD market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global AD market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Key Points from TOC:
1. Preface 2
2. Executive Summary 6
3. Introduction 9
4. Pipeline Assessment 15
4.1 Pipeline Overview 16
4.2 Pipeline Breakdown by Region/Country 18
4.3 Pipeline Breakdown by Molecule Type and Target 19
4.4 Drug Review Designations 20
4.5 Products in Clinical Development 21
5. Clinical Trial Assessment 23
6 Commercial Assessment 32
7. Competitive Landscape Analysis (2016-2026) 35
7.1 Events Classification Overview 36
7.2 US 37
7.3 5EU 38
7.4 Japan 39
7.5 China 40
8 Appendix 42
Get More Information about the Report@ http://www.orbisresearch.com/reports/index/alzheimers-disease-competitive-landscape-to-2026
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Information:
Orbis Research
Hector Costello
Tel: +1 (214) 884-6817
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Orbis Research
Hector Costello
Tel: +1 (214) 884-6817
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results